1-4 of 4
Anastasios Karadimitris, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Invariant NKT Are a More Effective and Versatile Platform Than T Cells for CAR Immunotherapy of CD1d-Expressing B Lineage Malignancies: Cellular and Molecular Mechanisms

Antonia Rotolo, MD, Olivier Dubois, Nicoleta Baxan, PhD, Suhail Chaudhry, PhD, Valentina Caputo, PhD, Katerina Goudevenou, PhD, Kyriaki Petevi, MD, Gordon W Cheung, Martin Pule, PhD, John Maher, PhD, Anastasios Karadimitris, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4613.
https://doi.org/10.1182/blood.V130.Suppl_1.4613.4613
Published: 2017
Journal Articles

Myeloma Cell Addiction to the Transcription Factor TCF11

Valentina Caputo, PhD, Katerina Goudevenou, PhD, Nikolaos Trasanidis, BSc, MSc, Kyriaki Petevi, MD, Xiaolin Xiao, PhD, Kanagaraju Ponnusamy, PhD, Deena Iskander, MD, David Pitcher, PhD, Antonia Rotolo, MD, Holger W. Auner, MD PhD, Aristeidis Chaidos, MD PhD, Anastasios Karadimitris, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1194.
https://doi.org/10.1182/blood.V130.Suppl_1.1194.1194
Published: 2017
Journal Articles

A Phase I Study of GSK525762, a Selective Bromodomain (BRD) and Extra Terminal Protein (BET) Inhibitor: Results from Part 1 of Phase I/II Open Label Single Agent Study in Patients with Acute Myeloid Leukemia (AML)

Mark Dawson, MD PhD, Eytan M. Stein, MD, Brian J.P Huntly, Anastasios Karadimitris, PhD, Manali Kamdar, Carlos Fernandez de Larrea, Michael J. Dickinson, Paul Sung-Hao Yeh, MBBS, FRCPA, FRACP, Naval Daver, MD, Aristeidis Chaidos, MD PhD, Martin S. Tallman, MD, Raquel Jiménez, MD, Thierry Horner, PhD, January Baron, MS, John Brennan, Geraldine Ferron-Brady, Yuehui Wu, PhD, Natalie Karpinich, Brandon Kremer, Arindam Dhar, MBBS,MDPhD, Gautam Borthakur, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1377.
https://doi.org/10.1182/blood.V130.Suppl_1.1377.1377
Published: 2017
Journal Articles

Glucose Ceramide Synthase Inhibitors Inhibit Osteoclast Activation Induced by Myeloma-Derived and De Novo Synthesized Glycosphingolipids.

Ke Xu, MD, Aristotelis Antonopoulos, PhD, Emmanouil Spanoudakis, MD, PhD, Simon Parry, PhD, Aristeidis Chaidos, MD, PhD, Ming Hu, PhD, Terry Butters, PhD, Anne Dell, PhD, Amin Rahemtulla, MBBS, PhD, FRCP, Nikki Horwood, PhD, Anastasios Karadimitris, PhD, MRCP, FRCPath
Journal: Blood
Blood (2009) 114 (22): 424.
https://doi.org/10.1182/blood.V114.22.424.424
Published: 2009